$WST News

Morgan Stanley Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $365

West Pharmaceutical Services (WST) Is Up 4.24% in One Week: What You Should Know

West to Host Second-Quarter 2026 Conference Call

Evercore ISI Group Maintains Outperform on West Pharmaceutical Servs, Raises Price Target to $410

West Pharmaceutical Services (WST) Stock Looks Overvalued Despite Upcoming Q2 Earnings

What to Expect From West Pharmaceutical Services' Q2 2026 Earnings Report

Keybanc Maintains Overweight on West Pharmaceutical Servs, Raises Price Target to $390

West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System

MMSI or WST: Which Is the Better Value Stock Right Now?

West Pharmaceutical Services (WST) Is Up 6.7% After 21% Revenue Jump On Injectable Demand - Has The Bull Case Changed?

West Pharmaceutical Services (WST) Stock Could Be 6.9% Undervalued on GLP 1 Growth Narrative

How Investors May Respond To West Pharmaceutical Services (WST) Upgraded 2026 Outlook And Biologics Momentum

Is West Pharmaceutical Stock Outperforming the S&P 500?

TXG Gains From Proteintech Deal, Expands Multiomics Capabilities

Here's Why You Should Add NeuroPace Stock to Your Portfolio Now

AMN Expands Language Services Portfolio With Jaide Health Deal

Barclays Upgrades West Pharmaceutical Services (WST)

Barclays Upgrades West Pharmaceutical Servs to Overweight, Raises Price Target to $400

Wolfe Research Says West Pharmaceutical Services (WST) is Positioned to Benefit from Injectable Drug Growth

Wolfe Research Weighs on West Pharmaceutical Services Inc (WST) Stock